Bernie Sanders hints at subpoena for Starbucks CEO Howard Schultz

Bernie Sanders hints at subpoena for Starbucks CEO Howard Schultz


Senator Bernie Sanders (I-VT) (L), Starbucks CEO Howard Schultz

Reuters (L) | Getty Images (R)

Sen. Bernie Sanders hinted that lawmakers could subpoena Howard Schultz to compel the outgoing Starbucks CEO to testify in front of a Senate panel about how the coffee chain is handling its baristas’ push to unionize.

“One way or another, he will be there,” Sanders told reporters on Capitol Hill. “But as you know, that’s not the decision of the chairman alone.”

Sanders, who chairs the Senate’s Health, Education, Labor and Pensions Committee, said in a statement Wednesday that he intends to hold Schultz and Starbucks accountable and looks forward to seeing Schultz appear before the committee.

A representative for Starbucks did not immediately respond to CNBC”s request for comment.

Schultz declined an invitation from 11 senators to appear at the March 9 hearing, Reuters reported Tuesday evening. Starbucks’ general counsel, Zabrina Jenkins, wrote in the letter viewed by Reuters that Schultz is leaving his role in March, so it makes more sense for another senior leader with ongoing responsibilities to testify instead.

The company has instead put chief public affairs officer AJ Jones II forward as the best person to address the committee.

Schultz owns 1.9% of Starbucks’ shares, according to Factset. The company’s market value stands at about $124.6 billion.

Nearly 290 company-owned Starbucks cafes in the U.S. have voted to unionize as of Monday, according to a tally from the National Labor Relations Board. Baristas’ union push began under Schultz’s predecessor — and one-time successor — Kevin Johnson. When Johnson resigned in the spring of 2021, Schultz returned to the helm and pushed back more aggressively against workers’ attempts to unionize.

To date, regional offices of the federal labor board have issued 76 complaints against Starbucks, alleging illegal labor practices. Most recently, the NLRB ruled Monday that Starbucks illegally fired two workers and broke other labor laws during a union drive at two Philadelphia locations in 2019, prior to the current union boom sweeping across the company.

The allegations of union busting have damaged Starbucks’ reputation as a progressive employer, although they don’t appear to have hurt the company’s U.S. sales. The chain reported U.S. same-store sales growth of 10% for its latest quarter, boosted by strong demand over the holiday season.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More